UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 189

Sortiert nach

Human kisspeptins activate neuropeptide FF2 receptor

Neuroscience, 2010-09, Vol.170 (1), p.117-122

2010

Volltextzugriff (PDF)

Pharmacological characterization and CNS effects of a novel highly selective α 2C ‐adrenoceptor antagonist JP‐1302

British journal of pharmacology, 2009-01, Vol.150 (4), p.391-402

2009

Volltextzugriff (PDF)

Pharmacological characterization and CNS effects of a novel highly selective α2C‐adrenoceptor antagonist JP‐1302

British journal of pharmacology, 2007-02, Vol.150 (4), p.391-402

2007

Volltextzugriff (PDF)

Identification and Characterization of the Imidazoline I2b-binding Sites in the Hamster Brown Adipose Tissue as a Study Model for Imidazoline Receptors

Archives of physiology and biochemistry, 2003-04, Vol.111 (2), p.159-166

2003

Volltextzugriff (PDF)

Cardiovascular actions of medetomidine and their reversal by atipamezole

Acta veterinaria Scandinavica. Supplementum, 1989, Vol.85, p.39

Savola, J M

1989

Volltextzugriff (PDF)

Assessing activation of the human neuropeptide FF2 receptor with a non-radioactive GTP binding assay

Peptides (New York, N.Y. : 1980), 2004-12, Vol.25 (12), p.2099-2104

2004

Volltextzugriff (PDF)

Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist

European journal of pharmacology, 1988-05, Vol.150 (1-2), p.9-14

1988

Volltextzugriff (PDF)

Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects

British journal of clinical pharmacology, 2018-10, Vol.84 (10), p.2422-2432

2018

Volltextzugriff (PDF)

Functional properties of PFR(Tic)amide and BIBP3226 at human neuropeptide FF2 receptors

Peptides (New York, N.Y. : 1980), 2003-12, Vol.24 (12), p.1947-1954

2003

Volltextzugriff (PDF)

Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinephrine and epinephrine

Molecular pharmacology, 2001-05, Vol.59 (5), p.1343-1354

2001

Volltextzugriff (PDF)

Anti-obesity effect of MPV-1743 A III, a novel imidazoline derivative, in genetic obesity

European journal of pharmacology, 1997-06, Vol.328 (2), p.207-215

1997

Volltextzugriff (PDF)

Synthesis and pharmacological properties of 4(5)-(2-ethyl-2,3-dihydro-2 silainden-2-yl)imidazole, a silicon analogue of atipamezole

European journal of medicinal chemistry, 1996, Vol.31 (9), p.725-729

1996

Volltextzugriff (PDF)

Central alpha 2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine

European journal of pharmacology, 1991-03, Vol.195 (2), p.193-199

1991

Volltextzugriff (PDF)

Three-dimensional models of alpha(2A)-adrenergic receptor complexes provide a structural explanation for ligand binding

The Journal of biological chemistry, 1999-08, Vol.274 (33), p.23405

1999

Volltextzugriff (PDF)

Peripheral cardiovascular α- and β-adrenergic effects of some hypotensive and bradycardic arylalkyl imidazole derivatives in the rat

Journal of pharmacy and pharmacology, 1985-06, Vol.37 (6), p.410-414

1985

Volltextzugriff (PDF)

Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors

The Journal of pharmacology and experimental therapeutics, 2003-06, Vol.305 (3), p.825

2003

Volltextzugriff (PDF)

Cardiovascular actions of detomidine

Acta veterinaria Scandinavica. Supplementum, 1986, Vol.82, p.47

Savola, J M

1986

Volltextzugriff (PDF)

Alpha 2A-adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1996-02, Vol.20 (2), p.185

1996

Volltextzugriff (PDF)

Differential efficacies of somatostatin receptor agonists for G-protein activation and desensitization of somatostatin receptor subtype 4-mediated responses

The Journal of pharmacology and experimental therapeutics, 2006-03, Vol.316 (3), p.1262

2006

Volltextzugriff (PDF)

α-adrenoceptor activity of arylalkylimidazoles is improved by α-methylation and impaired by α-hydroxylation

Naunyn-Schmiedeberg's archives of pharmacology, 1986-12, Vol.334 (4), p.423-429

SAVOLA, J.-M

1986

Volltextzugriff (PDF)

Cardiovascular action of detomidine, a sedative and analgesic imidazole derivative with α-agonistic properties

European journal of pharmacology, 1985-11, Vol.118 (1), p.69-76

1985

Volltextzugriff (PDF)

Superagonism at the human somatostatin receptor subtype 4

The Journal of pharmacology and experimental therapeutics, 2005-01, Vol.312 (1), p.332

2005

Volltextzugriff (PDF)

EVIDENCE FOR MEDETOMIDINE AS A SELECTIVE AND POTENT AGONIST α2-ADRENORECEPTORS

Journal of autonomic pharmacology, 1986-12, Vol.6 (4), p.275-284

1986

Volltextzugriff (PDF)

Pharmacological characterization and CNS effects of a novel highly selective alpha sub(2c)-adrenoceptor antagonist JP-1302

British journal of pharmacology, 2007-02, Vol.150 (4), p.391-402

2007

Volltextzugriff (PDF)

Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302

British journal of pharmacology, 2007-02, Vol.150 (4), p.391-402

2007

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(167)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(93)
Life Sciences & Biomedicine
(77)
Humans
(73)
Male
(62)
Biological And Medical Sciences
(59)
Female
(53)
Animals
(48)
Medical Sciences
(46)
Rats
(31)
Imidazoles - Pharmacology
(25)
Adult
(22)
Child
(22)
Pharmacology & Pharmacy
(21)
Adolescent
(20)
Endocrinology & Metabolism
(20)
Diabetes Mellitus, Type 1 - Immunology
(19)
Diabetes. Impaired Glucose Tolerance
(19)
Endocrine Pancreas. Apud Cells
(19)
Endocrinopathies
(19)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Human kisspeptins activate neuropeptide FF2 receptor

Pharmacological characterization and CNS effects of a novel highly selective α 2C ‐adrenoceptor antagonist JP‐1302

Pharmacological characterization and CNS effects of a novel highly selective α2C‐adrenoceptor antagonist JP‐1302

Identification and Characterization of the Imidazoline I2b-binding Sites in the Hamster Brown Adipose Tissue as a Study Model for Imidazoline Receptors

Cardiovascular actions of medetomidine and their reversal by atipamezole

Assessing activation of the human neuropeptide FF2 receptor with a non-radioactive GTP binding assay

Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist

Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects

Functional properties of PFR(Tic)amide and BIBP3226 at human neuropeptide FF2 receptors

Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinephrine and epinephrine

Anti-obesity effect of MPV-1743 A III, a novel imidazoline derivative, in genetic obesity

Synthesis and pharmacological properties of 4(5)-(2-ethyl-2,3-dihydro-2 silainden-2-yl)imidazole, a silicon analogue of atipamezole

Central alpha 2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine

Three-dimensional models of alpha(2A)-adrenergic receptor complexes provide a structural explanation for ligand binding

Peripheral cardiovascular α- and β-adrenergic effects of some hypotensive and bradycardic arylalkyl imidazole derivatives in the rat

Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors

Cardiovascular actions of detomidine

Alpha 2A-adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes

Differential efficacies of somatostatin receptor agonists for G-protein activation and desensitization of somatostatin receptor subtype 4-mediated responses

α-adrenoceptor activity of arylalkylimidazoles is improved by α-methylation and impaired by α-hydroxylation

Cardiovascular action of detomidine, a sedative and analgesic imidazole derivative with α-agonistic properties

Superagonism at the human somatostatin receptor subtype 4

EVIDENCE FOR MEDETOMIDINE AS A SELECTIVE AND POTENT AGONIST α2-ADRENORECEPTORS

Pharmacological characterization and CNS effects of a novel highly selective alpha sub(2c)-adrenoceptor antagonist JP-1302

Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302

Suchergebnisse filtern